Ovarian Carcinoma Masquerading as Ovarian Hyperstimulation Syndrome
- 11 January 1986
- journal article
- case report
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 65 (7) , 813-814
- https://doi.org/10.3109/00016348609161511
Abstract
Two patients receiving ovulation‐inducing drugs were found to have ovarian carcinoma. Since patients receiving such medication are prone to develop enlarged ovaries with or without the fully developed hyperstimulation syndrome, the diagnosis of ovarian tumors in such patients may be delayed or missed. It is therefore being suggested that an ovarian enlargement persisting for more than 4 weeks, or the finding of ovarian solid masses by sonography in patients receiving ovulation‐inducing drugs, should lead to a thorough work‐up for neoplasia, sometimes including even laparotomy.Keywords
This publication has 5 references indexed in Scilit:
- Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapyBJOG: An International Journal of Obstetrics and Gynaecology, 1982
- Massive Hyperstimulation and Borderline Carcinoma of the OvaryActa Obstetricia et Gynecologica Scandinavica, 1982
- DOES PREGNANCY PROTECT AGAINST OVARIAN CANCER?The Lancet, 1978
- Ovarian Overstimulation, Massive Ascites, and Singleton Pregnancy After ClomipheneJAMA, 1969
- SEROUS NEOPLASMS OF THE OVARYThe Lancet Healthy Longevity, 1965